Babak Javid, PhD
Associate Professor
Medicine
School of Medicine

babak.javid@ucsf.edu 628-206-8159

I am an infectious diseases physician-scientist. My research focuses on three questions with regards to why/how tuberculosis is the world's most successful (and deadly) bacterial pathogen:

Show full bio (80 words) Hide full bio

(1) how does alteration of the bacterial protein synthesis machinery (ribosomes, pre-ribosomal pathways) allow mycobacteria to adapt to hostile environments such as the host and antibiotic treatment? (2) what is the role and mechanism of antibody-mediated immunity to tuberculosis. (3) what the molecular mechanisms that allow Mycobacterium tuberculosis to survive antibiotics -- necessitating months-long treatment regimens.

I am always delighted to explore new collaborations and work with people who are curious and passionate about making exciting new discoveries.

Awards

Show all (3) Hide

  • Elected Member, American Society for Clinical Investigation, 2023---
  • Investigator, Wellcome Trust, 2017---
  • Young Immunologist of the Year, British Society for Immunology, 2003

Education & Training

Show all (7) Hide

  • Diversity Equity and Inclusion Champion training UCSF 2021
  • Postdoctoral training Harvard Chan School of Public Health 09/2011
  • Infectious Diseases Fellowship Cambridge University Hospitals 09/2007
  • PhD Immunobiology University of Cambridge 05/2006
  • Internal Medicine Residency Hammersmith & University College Hospitals 04/2001
  • MB BChir Medicine and Surgery University of Cambridge Clinical School 12/1997
  • BA Medical Sciences, Psychology & Neurobiology University of Cambridge 06/1995

Interests

Show all (6) Hide

  • tuberculosis
  • antibiotic tolerance
  • protein synthesis
  • immunology
  • ribosome biology
  • host-pathogen interactions

Websites

Show all (2) Hide

Grants and Projects

Show all (5) Hide

  • UCSF-UCB Tuberculosis Research Advancement Center (UC-TRAC), NIH, 2022-2027
  • A generalized strategy for bacterial antivirulence therapy, Kleberg Medical Research Foundation, 2023-2026
  • Antibiotic tolerance as a stepping stone to tuberculosis drug-resistance, NIAD, 2023-2025
  • Pre-clinical evaluation of novel subunit tuberculosis vaccines, Bill and Melinda Gates Foundation, 2021-2024
  • Molecular characterisation of antibiotic tolerance in Mycobacterium tuberculosis, Wellcome Trust, 2019-2024

Publications (57)

Top publication keywords:
MasksAntitubercular AgentsRifampinAntibodies, BacterialBacterial ProteinsMycobacterium tuberculosisMycobacteriumMycobacterium smegmatisTuberculosis VaccinesGene Expression Regulation, BacterialDrug Resistance, BacterialProtein BiosynthesisGenes, ReporterTuberculosisNitrogenous Group Transferases

Show all (50 more) Hide